Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34960635)
Watch
English
Osteoclast targeted therapy for prostate cancer: bisphosphonates and beyond
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Osteoclast targeted therapy for prostate cancer: bisphosphonates and beyond
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
main subject
prostate cancer
1 reference
based on heuristic
inferred from title
author name string
Matthew R Smith
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
publication date
1 July 2008
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
published in
Urologic Oncology
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
volume
26
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
page(s)
420-425
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
issue
4
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
cites work
Denosumab in postmenopausal women with low bone mineral density
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
8 July 2018
Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
8 July 2018
Osteoclast differentiation and activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
8 July 2018
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
8 July 2018
American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
8 July 2018
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
8 July 2018
Biochemical markers and skeletal metastases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
8 July 2018
Markers of bone turnover for the management of patients with bone metastases from prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
8 July 2018
Comparative tolerability of drug therapies for hypercalcaemia of malignancy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
8 July 2018
Overview of bisphosphonates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
8 July 2018
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
Avascular necrosis of the jaws: risk factors in metastatic cancer patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
Renal Failure with the Use of Zoledronic Acid
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090666
retrieved
26 October 2018
Osteoblast function and osteomalacia in metastatic prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.11.004
retrieved
7 January 2021
Morphometric evidence for bone resorption and replacement in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.11.004
retrieved
7 January 2021
Identifiers
DOI
10.1016/J.UROLONC.2007.11.004
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
Fatcat ID
release_v5kycixzgjgmzkezmat6ay4jr4
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/v5kycixzgjgmzkezmat6ay4jr4
retrieved
24 November 2022
based on heuristic
mapped directly with Wikidata item
PMCID
3090666
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
PubMed ID
18593621
1 reference
stated in
Europe PubMed Central
PubMed ID
18593621
retrieved
5 August 2017
ResearchGate publication ID
5259054
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit